Replies to post #19748 on Genta, Inc (fka GNTAQ)

[surfmore]

"We currently project that the final assessment of progression-free survival (PFS) will be analyzed approximately 6 months after the last patient has been enrolled. If positive, we plan discussions with global regulatory agencies regarding submissions for marketing approval based on this result coupled with our extensive prior data.”
That would be mid october.

[surfmore]

So they will be getting feedback (preliminary) results prior to completion in mid october.